Big brother, big business
| May 17, 2013 | Cardiovascular Business | Patient Care

Marketing intelligence firms that serve pharmaceutical companies apply sophisticated networking and data analytics to inform their clients about the prescribing habits of physicians as well as patient behavior. “Doctors tend not to be aware of the depths to which they are being analyzed and studied by people trying to sell them drugs and other medical products,” Jerry Avorn, MD, chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital in Boston, said in a New York Times article.

Pills tracked from doctor to patient to aid drug marketing

Related Content

Cardiologist moves to Mississippi to fight back against PAD and limit amputations
On-pump vs. off-pump CABG: No difference in long-term mortality, meta-analysis confirms
Peripheral artery disease is out of control in many rural, low income communities
The many benefits of using low-cost CT coronary calcium scoring to screen patients
Early feasibility study for implantable heart failure monitor moves forward 
Using 'magic' to calm pediatric patients during imaging exams

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business
Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Design by Adaptive Theme
Trimed Popup
Trimed Popup